Arcutis Biotherapeutics, Inc. (ARQT)

NASDAQ: ARQT · Real-Time Price · USD

24.82

+0.82 (3.42%)

At close: Mar 9, 2026, 4:00 PM EDT

24.70

-0.12 (-0.48%)

After-hours: Mar 9, 2026, 6:20 PM EDT

Arcutis Biotherapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	43.22	71.95	89.32	54.88	97.99
Short-Term Investments	178.08	156.62	183.46	355.95	290.61
Cash & Short-Term Investments	221.29	228.57	272.79	410.82	388.6
Cash Growth	-3.19%	-16.21%	-33.60%	5.72%	35.88%
Accounts Receivable	146.23	73.07	25.81	8.46	-
Inventory	22.63	14.53	13.13	7.51	-
Other Current Assets	21.08	19.66	18.7	10.61	14.17
Total Current Assets	411.23	335.82	330.43	437.41	402.77
Net Property, Plant & Equipment	5.51	2.99	3.9	4.6	5.3
Other Intangible Assets	14.81	9.48	6.44	7.19	-
Other Long-Term Assets	1.42	0.6	0.6	0.08	0.08
Total Assets	432.97	348.89	341.37	449.27	408.15
Accounts Payable	12.53	14.22	11.99	8.83	7.35
Accrued Expenses	116.31	66.79	33.94	28.32	25.54
Current Portion of Long-Term Debt	1	-	-	-	-
Current Portion of Leases	-	-	0.74	0.66	0.43
Total Current Liabilities	129.84	81.01	46.67	37.81	33.33
Long-Term Debt	107.96	107.2	201.8	197.77	72.35
Long-Term Leases	5.27	2.56	3.38	4.12	4.77
Other Long-Term Liabilities	0.43	0.57	0.85	-	0.03
Total Long-Term Liabilities	113.66	110.34	206.03	201.89	77.15
Total Liabilities	243.49	191.35	252.7	239.69	110.48
Common Stock	0.01	0.01	0.01	0.01	0.01
Additional Paid-in Capital	1,328	1,279	1,071	930.43	706.23
Accumulated Other Comprehensive Income	-0.04	-0.01	0	-1.09	-0.26
Retained Earnings	-1,138	-1,122	-981.9	-719.76	-408.31
Shareholders' Equity	189.48	157.54	88.67	209.58	297.68
Total Liabilities & Equity	432.97	348.89	341.37	449.27	408.15
Total Debt	114.23	109.77	205.92	202.54	77.56
Net Cash (Debt)	107.07	118.81	66.87	208.28	311.04
Net Cash Growth	-9.88%	77.67%	-67.89%	-33.04%	10.68%
Net Cash Per Share	0.84	0.98	0.96	3.79	6.30
Book Value	189.48	157.54	88.67	209.58	297.68
Book Value Per Share	1.49	1.30	1.28	3.81	6.03
Tangible Book Value	174.67	148.06	82.23	202.39	297.68
Tangible Book Value Per Share	1.37	1.22	1.19	3.68	6.03

Updated Feb 25, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q